Indeloxazine (Elen, Noin) is an antidepressant and cerebral activator [1] [2] that was marketed in Japan and South Korea by Yamanouchi Pharmaceutical Co., Ltd for the treatment of …

Indeloxazine | C14H17NO2 | CID 3704 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity …

1.具有复活大脑皮质自发脑波的作用，因而可改善记忆和脑震荡所致的行动障碍，以及延长缺氧环境下的生存时间。 还具有抗抑郁作用，因对 5-羟色胺 、组胺受体有弱的亲和力。 2.口 …

2020年12月9日 · Indeloxazine enhanced passive learned behaviour in rats and ameliorated cerebral ischemia-induced learned disturbances in gerbils. Reserpine-induced hypothermia in …

1989年12月1日 · In biochemical studies, indeloxazine increased the extracellular concentration of acetylcholine in the frontal cortex of mature rats. These results suggest that indeloxazine …

Bifemelane hydrochloride (bifemelane), idebenone and indeloxazine hydrochloride (indeloxazine) are used clinically to reduce apathy and other emotional disturbances in patients with …

茚洛秦 （Indeloxazine），商品名 茚氯嗪、茚罗西生、茚洛西亚。 本药品被归类到 心律失常 等药品分类。 A+医学百科茚洛秦条目介绍茚洛秦的功效作用，茚洛秦的副作用和服用方法等。 茚 …

盐酸茚洛秦: 一种SERT抑制剂、SLC6A2 modulators药物，由Astellas Pharma, Inc. (Astellas Pharma, Inc.)公司最早进行研发，目前全球最高研发状态为撤市，作用机制: SERT抑制剂 (5-羟 …

Indeloxazine is a neuroleptic, originally developed and marketed in Japan. It is indicated to allay autonomic hyperactivity following cerebral infarction, cerebral haemorrhage or atherosclerosis. …

盐酸茚洛秦是由默克和安斯泰来制药集团研发的一种小分子药物，是一种MAO抑制剂。 目前该药物最高研发阶段为撤市，用于治疗抑郁。